Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of quadrivalent HPV vaccine to prevent recurrence of external genital warts
2016-002455-20Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anogenital warts comparing Gardasil with Placebo (2 arms). Primary endpoint: Relapse-free survival at 12 months. Started Dec 2016; status: active.
02
Drugs
qHPV vaccine
03
Conditions
anogenital warts
Beyond the preview
Go deeper on 2016-002455-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002455-20.